LI
ACHN

LMCG Investments’s Achillion Pharmaceuticals ACHN Stock Holding History

LMCG Investments’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$273K Buy
39,503
+3,490
+10% +$28.4K 0.01% 512
2015
Q2 		$319K Buy
36,013
+2,544
+8% +$24.1K 0.01% 498
2015
Q1 		$330K Buy
33,469
+14,669
+78% +$183K 0.01% 509
2014
Q4 		$230K Buy
18,800
+7,817
+71% +$95.5K 0.01% 490
2014
Q3 		$110K Buy
+10,983
New +$102K ﹤0.01% 460

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LMCG Investments's ACHN Position: Q3 2015 in Review

LMCG Investments increased its Achillion Pharmaceuticals (ACHN) stake by 9.7% in Q3 2015, buying an estimated $28.4K and bringing the position to 39,503 shares worth $273K. The position accounts for 0.01% of the portfolio, ranked #512.

LMCG Investments first reported a position in ACHN in Q3 2014 and has held it in 5 quarters since. The position peaked at $330K in Q1 2015. 141 funds tracked by Wall St. Rank hold ACHN as of Q3 2015.

  • LMCG Investments held 39,503 shares of Achillion Pharmaceuticals worth $273K as of Q3 2015.
  • LMCG Investments bought 3,490 Achillion Pharmaceuticals shares in Q3 2015, an estimated $28.4K.
  • Achillion Pharmaceuticals made up 0.01% of LMCG Investments's portfolio in Q3 2015, its #512 holding.
  • LMCG Investments first reported a position in Achillion Pharmaceuticals in Q3 2014 and has held it in 5 quarters since.
  • LMCG Investments's Achillion Pharmaceuticals position peaked at $330K in Q1 2015.
  • 141 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q3 2015.

Based on LMCG Investments's 13F filing for Q3 2015, filed 4 Nov 2015.